J. Kim

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Jeong H. Kim, Jeong-han Kim, Jeong Han Kim
Publication record
105 papers · 1,616 citations · H-index 20

PAPERS

Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
20245 citationsauthor #1
자가면역간염의 진단
20232 citationsauthor #1
MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
20231 citationsauthor #2
Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers
20222 citationsauthor #2
Changes in the Hepatitis B Surface Antigen Level According to the HBeAg Status and Drug Used in Long-term Nucleos(t)ide Analog-treated Chronic Hepatitis B Patients
20213 citationsauthor #2
Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol
202115 citationsauthor #3
The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
20213 citationsauthor #3
Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
20202 citationsauthor #2
Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis
20209 citationsauthor #3
Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients
20208 citationsauthor #2
Clinical Score System to Differentiate Severe Fever with Thrombocytopenia Syndrome Patients from Patients with Scrub Typhus or Hemorrhagic Fever with Renal Syndrome in Korea
202010 citationsauthor #5
Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations
20195 citationsauthor #6
Co-Infection of Scrub Typhus and Human Granulocytic Anaplasmosis in Korea, 2006
20195 citationsauthor #1
FRI-205-Entecavir improves liver function and fibrosis in hepatitis B virus-associated cirrhosis: A 6 years-multicenter study
20190 citationsauthor #3
Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment
201920 citationsauthor #8
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
2019415 citationsauthor #49
Delays in Isolating Patients Admitted to Hospital with Pulmonary Tuberculosis in Korea
201910 citationsauthor #3
Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study
201921 citationsauthor #7
Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors
201819 citationsauthor #17
Prognosis of Spontaneous Bacterial Peritonitis in Hepatocellular Carcinoma Patients
20184 citationsauthor #1
Prognostic Impact of Hepatitis B or C on the Intrahepatic Cholangiocarcinoma
20176 citationsauthor #7
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
20176 citationsauthor #5
Treatment of Chronic Hepatitis C Patients Who Do Not Respond to Direct Acting Antivirals
20170 citationsauthor #1
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
201710 citationsauthor #8
Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center.
20172 citationsauthor #2
Current status of and strategies for hepatitis C control in South Korea
201723 citationsauthor #3
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
20166 citationsauthor #1
Survival Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients Treated with Sorafenib
20160 citationsauthor #1
Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
201622 citationsauthor #1
Efficacy and Safety of Tenofovir Disoproxil Furmarate for Patients with Lamivudine-Resistant Hepatitis B Virus Infection
20160 citationsauthor #6
Variceal Bleeding from Anastomosis Site after Total Gastrectomy with Esophagojejunostomy
20160 citationsauthor #2
Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis
201619 citationsauthor #12
Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus–related Cirrhosis Patients Receiving Antivirals
20163 citationsauthor #7
Needs of Treatment Strategies for Decreasing Mortality of Pyogenic Liver Abscess Patients
20160 citationsauthor #1
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
201657 citationsauthor #12
Portal biliopathy treated with endoscopic biliary stenting
20164 citationsauthor #7
Efficacy and Safety of Balloon-Occluded Retrograde Transvenous Obliteration with Sodium Tetradecyl Sulfate Liquid Sclerotherapy
201612 citationsauthor #8
Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naïve Chronic Hepatitis B patients
201514 citationsauthor #11
Improvement of liver function and non‐invasive fibrosis markers in hepatitis B virus‐associated cirrhosis: 2 years of entecavir treatment
201520 citationsauthor #2
[A Case of Delayed-onset Multiple Metastatic Infection following Liver Abscess].
20155 citationsauthor #5
What we know about paracentesis induced circulatory dysfunction?
20159 citationsauthor #1
P0164 : Clinical significance of subclinical ascites in Korean patients with hepatitis B virus-related liver cirrhosis: A multicenter, retrospective study
20150 citationsauthor #7
Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
201514 citationsauthor #5
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
20142 citationsauthor #1
Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal
201442 citationsauthor #2
A Case of Hepatocellular Carcinoma with Improved Decompansated Liver Cirrhosis with Combination Treatment of Transarterial Chemoembolization and Radiofrequency Ablation
20140 citationsauthor #4
A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation
201412 citationsauthor #2
Sorafenib Combined with Transarterial-Chemoembolization in Child-Pugh Class B Patients with Hepatocellular Carcinoma
20140 citationsauthor #9
Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy
201413 citationsauthor #4
The Impact of the Hepatitis B Virus Polymerase rtA181T Mutation on Replication and Drug Resistance Is Potentially Affected by Overlapping Changes in Surface Gene
201439 citationsauthor #4
Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma.
201428 citationsauthor #5
Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study
20148 citationsauthor #2
The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
20148 citationsauthor #2
Noninvasive Panels for Fibrosis Predict 5-year Mortality and Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
20140 citationsauthor #2
Molecular diagnosis and treatment of drug-resistant hepatitis B virus.
201446 citationsauthor #1
The Effect of HBV DNA Level on the Development of HCC in Liver Cirrhosis during Entecavir Treatment
20140 citationsauthor #5
Predictive value of Refit Model for End‐Stage Liver Disease, Refit Model for End‐Stage Liver Disease‐Na, and pre‐existing scoring system for 3‐month mortality in Korean patients with cirrhosis
201315 citationsauthor #2
Value of the APASL severity score in patients with acute variceal bleeding: a single center experience
20132 citationsauthor #2
Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure
201314 citationsauthor #3
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
20138 citationsauthor #1
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
20132 citationsauthor #1
Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients
20132 citationsauthor #5
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus‐related decompensated cirrhosis
201235 citationsauthor #8
Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B.
201221 citationsauthor #1
Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
201241 citationsauthor #6
Prospective, randomized, back-to-back trial evaluating the usefulness of i-SCAN in screening colonoscopy.
2012114 citationsauthor #7
Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea.
201245 citationsauthor #3
Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study
20128 citationsauthor #1
Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy
201219 citationsauthor #4
Pharmacotherapy alone vs endoscopic variceal ligation combination for secondary prevention of oesophageal variceal bleeding: meta‐analysis
201210 citationsauthor #2
Clonal evolution of hepatitis B virus polymerase gene mutations during lamivudine-adefovir combination treatment.
20125 citationsauthor #5
Carotid Intima-Media Thickness Is Increased Not Only in Non-Alcoholic Fatty Liver Disease Patients but Also in Alcoholic Fatty Liver Patients
201116 citationsauthor #1
Effectiveness and Safety of Repeated Quadruple Therapy in Helicobacter pylori Infection After Failure of Second‐line Quadruple Therapy
201116 citationsauthor #7
Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
201112 citationsauthor #5
Clinical features of acute viral hepatitis B in Korea: a multi-center study
201116 citationsauthor #13
Validation of a Mayo post‐operative mortality risk prediction model in Korean cirrhotic patients
201135 citationsauthor #4
Focal hepatic steatosis that appears as a liver mass in imaging.
20111 citationsauthor #1
Hepatitis C, LC : Pharmacotherapy alone versus EVL combination for secondary prevention of esophageal varix bleeding; meta-analysis (초)
20110 citationsauthor #1
Comparison of Clevudine and Entecavir for Treatment-naive Patients With Chronic Hepatitis B Virus Infection: Two-Year Follow-up Data
201118 citationsauthor #5
W1008 Atrophic Change in the Gastric Body on Endoscopy is Associated With Decreased Bone Mineral Density in Premenopausal Women
20100 citationsauthor #5
Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B.
20103 citationsauthor #5
Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases
201030 citationsauthor #4
EFFECT OF FRESH FROZEN PLASMA (FFP) TRANSFUSION ON PROTHROMBIN TIME (PT) AND BLEEDING CONTROL IN PATIENTS WITH CHRONIC LIVER DISEASE
20100 citationsauthor #7
S1905 Efficacy of Radiofrequency Ablation for Early Stage Hepatocellular Carcinoma
20100 citationsauthor #1
M1121 Comparative Study of Helicobacter pylori Eradication Rates of Three-Times-Daily High Dose Lansoprazole/Amoxicillin Dual Therapy Versus Standard Triple Therapy
20100 citationsauthor #4
1147 CAROTID INTIMA-MEDIA THICKNESS IS INCREASED IN FATTY LIVER PATIENTS EVEN IF NOT INCLUDED IN NON-ALCOHOLIC FATTY LIVER DISEASE
20100 citationsauthor #1
A Case of Massive Hepatocellular Carcinoma Treated by Hepatic Resection, which did not Respond to Transarterial Chemoembolization
20090 citationsauthor #1
A Case of Hepatocellular Carcinoma with Early Multiple Recurrences after Liver Resection
20090 citationsauthor #4
Hepatitis B Viral Surface Mutations in Patients with Adefovir Resistant Chronic Hepatitis B with A181T/V Polymerase Mutations
200923 citationsauthor #1
Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels
200942 citationsauthor #4
Clinicopathological Features of Gastric Cancer Detected By Endoscopy and the Efficacy of Endoscopic Screening
20090 citationsauthor #4
[Clinical characteristics of chronic pancreatitis according to the history of pancreatitis].
20092 citationsauthor #5
Trend in the eradication rates of Helicobacter pylori infection in the last 11 years
200919 citationsauthor #9
[Two cases of toxic hepatitis caused by arrowroot juice].
200921 citationsauthor #4
Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
20099 citationsauthor #1
[Changes in liver stiffness after acute or chronic liver injury due to viral hepatitis--does fibrosis exist after recovery from acute viral hepatitis?].
20092 citationsauthor #1
[A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy].
20092 citationsauthor #5
986 CHRONIC ETHANOL CONSUMPTION MODULATE THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) IN C57BL/6J ANIMAL MODEL
20080 citationsauthor #2
Changing pattern of microorganisms and antibiotic resistance rate of spontaneous bacterial peritonitis: A 12-year experience
20082 citationsauthor #6
Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment
20087 citationsauthor #6

TIMELINE

2004 13 citations

2008 9 citations

2009 120 citations

2010 33 citations

2011 114 citations

2012 298 citations

2013 43 citations

2014 198 citations

2015 62 citations

2016 123 citations

2017 47 citations

2018 23 citations

2019 476 citations

2020 29 citations

2021 21 citations

2022 2 citations

2023 3 citations

2024 5 citations

J. Kim

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT